Cirsium Biosciences is developing a plant-based manufacturing platform designed to significantly reduce the production time and cost of viral vector-based gene therapies. Their innovative approach aims to establish a scalable and cost-effective process for producing viral vectors, achieving up to an 80% reduction in manufacturing lead times for AAV gene therapies. This platform addresses the growing demand for gene therapies and aims to alleviate potential shortages of specific vector types.
Leadership & Board
Current Number of Employees30
Current LinkedIn Followers4,287
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$61M
Total Amount Raised$61M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$61M
Latest Funding Amount$61M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Cirsium Biosciences had 30 employees as of October 12, 2026. The number of employees increased by 1 (3.45%) week-over-week.
30Latest Employee Count
1(3.45%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Cirsium Biosciences had 4,287 followers as of October 12, 2026. The number of followers increased by 58 (1.37%) week-over-week.
4,287Latest Followers Count
58(1.37%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Investment
$61.00M
―
Similar Companies
A snapshot of private companies similar to Cirsium Biosciences, helping you discover and navigate related company profiles.